CASE REPORT
Case report of dystrophic epidermolysis bullosa confirmed by genetic analysis
Submission date: 2015-01-16
Final revision date: 2015-03-07
Acceptance date: 2015-08-05
Publication date: 2015-10-23
Medical Studies 2015;31(3):200-202
KEYWORDS
TOPICS
ABSTRACT
Dystrophic epidermolysis bullosa is an inherited disease presenting with blistering of the skin in the subdermal layer caused by gene COL7A1 mutations. The authors reviewed a case of this disease determined by two mutations: dominant and recessive. The disease presented with blisters all over the patient’s body, mostly on the neck, back, and inguinal area, as well as on the hands and feet. The symptom that most affected the patient’s quality of life was severe blistering and ulceration in the pharynx, mucous membrane of the mouth, and perianal area. There is no effective treatment today, only procedures to relieve complications like oesophageal obstructions.
REFERENCES (15)
1.
Fine JD. Inherited epidermolysis bullosa: past, present, and future. Ann N Y Acad Sci 2010; 1194: 213-22.
2.
Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70: 1103-26.
3.
Davila-Seijo P, Hernández-Martin A, Morcillo-Makow E, et al. Prioritization of therapy uncertainties in dystrophic epidermolysis bullosa: where should research direct to? an example of priority setting partnership in very rare disorders. Orphanet J Rare Dis 2013; 8: 61.
4.
QueirozFuscaldi LAN, Buçard AM, Alvarez CDQ, Barcaui CB. Epidermolysis bullosa nevi: report of a case and review of the literature. Case Rep Dermatol 2011; 3: 235-9.
5.
Frew JW, Martin LK, Nijsten T, Murrell DF. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol 2009; 161: 1323-30.
6.
Christiano AM, Bart BJ, Epstein EH, Uitto J. Genetic basis of Bart’s syndrome: a glycine substitution mutation in type VII collagen gene. J Invest Dermatol 1996; 106: 778-80.
7.
Kahofer K, Bruckner-Tuderman L, Metze D, et al. Dystrophic Epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/F3 protein. Pediatr Dermatol 2003; 20: 243-8.
8.
Akker P, Mellerio JE, Martinez AE, et al. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J Med Genet 2011; 48: 160-7.
9.
Jerabkova B, Kopeckova L, Buckova H, et al. Analysis of the COL7A1 gene in Czech patients with dystrophic epidermolysis bullosa reveals novel and recurrent mutations. J Dermatol Sci 2010; 59: 136-40.
10.
Ortiz-Urda S, Garcia J, Green CL, et al. Type VII collagen is required for Ras-driven human epidermal tumorogenesis. Science 2005; 307: 1773-6.
11.
Pourreyron C, Cox G, Mao1 X, et al. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of tpe VII collagen expression. J Investig Dermatol 2007; 127: 2438-44.
12.
Hsu CK, Wang SP, Lee JY, McGrath JA. Treatment of hereditary epidermolysis bullosa: updates and future prospects. Am J Clin Dermatol 2014; 15: 1-6.
13.
Lees CJ, Eide C, Keene DR, et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2014; 134: 1246-54.
14.
Tolar J, Wagner JE. Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet 2013; 382: 1214-23.
15.
Cutlar L, Greiser U, Wang W. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa. Exp Dermatol 2014; 23: 1-6.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
